Page last updated: 2024-12-05

aloe emodin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Aloe emodin is a natural anthraquinone derivative found in plants like aloe vera, rhubarb, and senna. It has been studied for its potential therapeutic effects, including anti-inflammatory, antioxidant, and anti-cancer activities. Its synthesis is typically achieved through the extraction and purification processes from natural sources. The compound is studied for its potential in treating conditions like inflammatory bowel disease, diabetes, and skin disorders. It is also used as a coloring agent in food and cosmetics.'

aloe emodin: structure distinct from emodin; this does not mean emodin from aloe [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Aloe emodin : A dihydroxyanthraquinone that is chrysazin carrying a hydroxymethyl group at position 3. It has been isolated from plant species of the genus Aloe. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
AloegenusA plant genus of the family Xanthorrhoeaceae which is used medicinally. It contains anthraquinone glycosides such as aloin-emodin or aloe-emodin (EMODIN).[MeSH]Asphodelaceae[no description available]

Cross-References

ID SourceID
PubMed CID10207
CHEMBL ID40275
CHEBI ID2607
SCHEMBL ID309756
MeSH IDM0007303

Synonyms (83)

Synonym
AC-020
NSC38628 ,
NCI60_003685
3-hydroxymethylchrysazine
ccris 3526
1,8-dihydroxy-3-(hydroxymethyl)anthraquinone
brn 2059062
anthraquinone, 1,8-dihydroxy-3-hydroxymethyl-
einecs 207-571-7
rhabarberone
aloe emodin
anthraquinone,8-dihydroxy-3-(hydroxymethyl)-
1,8-dihydroxy-3-hydroxymethylanthraquinone
9, 1,8-dihydroxy-3-(hydroxymethyl)-
nsc-38628
3-hydroxymethylchrysazin
emodine
9,10-anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)-
1,8-dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone
inchi=1/c15h10o5/c16-6-7-4-9-13(11(18)5-7)15(20)12-8(14(9)19)2-1-3-10(12)17/h1-5,16-18h,6h
1,8-dihydroxy-3-hydroxymethyl-anthraquinone
1,8-dihydroxy-3-(hydroxymethyl)-9,10-anthracenedione
nsc 38628
aloe-emodin ,
481-72-1
1,8-dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione
aloe-emodin, >=95% (hplc)
smr000470920
MLS000697563
NCGC00163510-02
NCGC00163510-01
SMP2_000291
LMPK13040002
cid_10207
bdbm50085551
chebi:2607 ,
CHEMBL40275 ,
AKOS005720864
aloeemodin
dtxcid0010695
tox21_302400
NCGC00255349-01
cas-481-72-1
dtxsid2030695 ,
STL146380
unii-c8iyt9cr7c
c8iyt9cr7c ,
4-08-00-03578 (beilstein handbook reference)
FT-0622062
NCGC00163510-03
S2259 ,
anthraquinone, 1,8-dihydroxy-3-(hydroxymethyl)-
aloe-emodin [mi]
dihydroxy-3-hydroxymethylanthraquinone, 1,8-
CCG-208456
SCHEMBL309756
BBL027838
aloe-emodine
CS-3709
3-(hydroxymethyl)chrysazin
9,10-dihydro-4,5-dihydroxy-9,10-dioxo-2-hydroxymethyl-anthracene
MLS006011799
Q-100526
aloe-emodol
1,8-dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone #
HY-N0189
mfcd00017373
aloe-emodin, analytical standard
SR-01000765772-3
sr-01000765772
HMS3655N16
diacerein impurity b, european pharmacopoeia (ep) reference standard
1,8-dihydroxy-3-(hydroxymethyl)-anthracene-9,10-dione (aloe-emodin)
1,8-dihydroxy-3-hydroxymethyl-9,10-anthracenedione, 9ci
rottlerin?
SW219916-1
Q3533249
aloe-emodine,(s)
AS-11638
BCP28272
1,8-dihydroxy-3-(hydroxymethyl)-9,10-dihydroanthracene-9,10-dione
EX-A6788
aloeemodine

Research Excerpts

Overview

Aloe emodin is a natural anthraquinone derived from aloe or rhubarb, showing anti-renal fibrosis, anti-atherosclerosis and anti-cancer effects. It could be used to treat hyperlipidemia, thereby reducing the risk of cardiovascular disease.

ExcerptReferenceRelevance
"Aloe emodin is a natural anthraquinone derived from aloe or rhubarb, showing anti-renal fibrosis, anti-atherosclerosis and anti-cancer effects. "( Neuroprotective effect of aloe emodin against Huntington's disease-like symptoms in R6/1 transgenic mice.
Cao, J; Chen, J; Gao, H; Jin, G; Li, X; Liu, S; Niu, Y; Wang, S; Wang, Y; Wei, P; Yan, N; Yu, Y, 2023
)
2.65
"Aloe emodin (AE) is a lipid-lowering agent, which could be used to treat hyperlipidemia, thereby reducing the risk of cardiovascular disease. "( Aloe Emodin Reduces Cardiac Inflammation Induced by a High-Fat Diet through the TLR4 Signaling Pathway.
Chen, Y; Du, Z; Fan, Z; Feng, B; Hu, J; Jiang, H; Li, W; Yuan, Y; Zhao, W, 2020
)
3.44

Effects

ExcerptReferenceRelevance
"Aloe emodin has been reported to be nontoxic for normal cells but to possess specific toxicity for neuroectodermal tumor cells."( The effect of aloe emodin on the proliferation of a new merkel carcinoma cell line.
Avigad, S; Beery, E; Fenig, E; Nordenberg, J; Wasserman, L, 2002
)
1.4

Actions

ExcerptReferenceRelevance
"Aloe emodin could also inhibit neuronal apoptosis in the hippocampus of R6/1 mice."( Neuroprotective effect of aloe emodin against Huntington's disease-like symptoms in R6/1 transgenic mice.
Cao, J; Chen, J; Gao, H; Jin, G; Li, X; Liu, S; Niu, Y; Wang, S; Wang, Y; Wei, P; Yan, N; Yu, Y, 2023
)
1.93

Treatment

The aloe emodin treatment was applied to the JB6 C141 cell neoplastic model. Aloe emmodin-treated cells exhibited cell shrinkage along with distortion of the normal cell morphology. AlOE emod in treatment of t-HSC/Cl-6 cells caused activation of caspase-3 and caspases-9.

ExcerptReferenceRelevance
"The aloe emodin treatment was applied to the JB6 C141 cell neoplastic model."( Aloe emodin suppresses EGF‑induced neoplastic cell transformation by inhibiting the ERK/MSK1 and AKT/GSK3β signaling pathways.
Dong, Z; Guo, L; Liu, K; Zhang, J; Zhang, Q, 2018
)
2.4
"Aloe emodin-treated cells exhibited cell shrinkage along with distortion of the normal cell morphology."( Aloe emodin exerts potent anticancer effects in MIAPaCa-2 and PANC-1 human pancreatic adenocarcinoma cell lines through activation of both apoptotic and autophagic pathways, sub-G1 cell cycle arrest and disruption of mitochondrial membrane potential (ΛΨm)
Du, Y; Huang, M; Tao, Z; Wang, C; Yan, S; Zhang, J; Zhang, X,
)
2.3
"Aloe emodin treatment of t-HSC/Cl-6 cells caused activation of caspase-3 and caspase-9, detected with a caspase activity assay, although no change was observed in caspase-8 activity."( Aloe emodin-induced apoptosis in t-HSC/Cl-6 cells involves a mitochondria-mediated pathway.
Lian, LH; Park, EJ; Piao, HS; Sohn, DH; Zhao, YZ, 2005
)
2.49

Toxicity

ExcerptReferenceRelevance
" Nevertheless, the mechanisms of the toxic action of AE have not yet been fully clarified."( Metabolic Activation and Cytotoxicity of Aloe-Emodin Mediated by Sulfotransferases.
Guo, X; Li, R; Li, W; Peng, Y; You, Y; Zheng, J, 2019
)
0.51
" However, an increasing number of published studies have reported adverse effects of aloe-emodin."( Aloe-emodin: A review of its pharmacology, toxicity, and pharmacokinetics.
Dong, X; Fu, J; Liu, Y; Ni, J; Yin, X; You, L; Zeng, Y, 2020
)
0.56

Pharmacokinetics

ExcerptReferenceRelevance
"A validated high-performance liquid chromatography (HPLC) method was developed for simultaneous determination and pharmacokinetic study of aloe emodin and chrysophanol in rats."( Simultaneous determination and pharmacokinetic studies of aloe emodin and chrysophanol in rats after oral administration of Da-Cheng-Qi decoction by high-performance liquid chromatography.
Chen, GY; Huang, X; Liang, MZ; Qin, F; Tang, WF; Wan, MH; Wang, YG; Yu, Q, 2007
)
0.79
" The levels of aloe-emodin, rhein, emodin, chrysophanol, honokiol, magnolol, hesperidin, and naringin in rat serum were quantified using a liquid chromatography tandem mass spectrometry (LC-MS/MS) method for pharmacokinetic study."( Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats.
Chen, GY; Gong, HL; Huang, X; Tang, WF; Wang, J, 2012
)
0.38
"The area under the curve (AUC), mean retention time (MRT), the peak concentration (C(max)) of aloe-emodin, rhein, emodin, and chrysophanol in the DCQD group were significantly different compared with the Dahuang group (P <0."( Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats.
Chen, GY; Gong, HL; Huang, X; Tang, WF; Wang, J, 2012
)
0.38
"The compatibility in Chinese medicine could affect the drug's pharmacokinetics in DCQD, which proves that the prescription compatibility principle of Chinese medicine formulations has its own pharmacokinetic basis."( Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats.
Chen, GY; Gong, HL; Huang, X; Tang, WF; Wang, J, 2012
)
0.38
" The developed method was successfully applied to a pharmacokinetic study of aloe-emodin, rhein and emodin in rats' plasma after oral administration."( Comparative pharmacokinetics of aloe-emodin, rhein and emodin determined by liquid chromatography-mass spectrometry after oral administration of a rhubarb peony decoction and rhubarb extract to rats.
Cai, BC; Chen, LH; Li, JS; Liu, X; Peng, WW; Yang, GM; Zhang, YX, 2013
)
0.39
" This study was designed to confirm the expected synergistic effects of RGHP at pharmacodynamic and pharmacokinetic levels."( Synergistic effects of rhubarb-gardenia herb pair in cholestatic rats at pharmacodynamic and pharmacokinetic levels.
Dong, LC; Dong, X; Fan, YX; Li, HJ; Li, P; Ma, J; Yu, Q, 2015
)
0.42
" For pharmacodynamic study, biochemical and histopathological tests were performed to assess the hepatoprotective effects."( Synergistic effects of rhubarb-gardenia herb pair in cholestatic rats at pharmacodynamic and pharmacokinetic levels.
Dong, LC; Dong, X; Fan, YX; Li, HJ; Li, P; Ma, J; Yu, Q, 2015
)
0.42
" The pharmacokinetic study indicated RGHP could significantly elevate systemic exposure level and prolong retention time of five markers in comparison with rhubarb or gardenia alone."( Synergistic effects of rhubarb-gardenia herb pair in cholestatic rats at pharmacodynamic and pharmacokinetic levels.
Dong, LC; Dong, X; Fan, YX; Li, HJ; Li, P; Ma, J; Yu, Q, 2015
)
0.42
"The present study demonstrated the synergistic effects of RGHP in ANIT-induced cholestatic rats at pharmacodynamic and pharmacokinetic levels, and has significant enlightenments for the rational use of the related TCM formulas containing RGHP."( Synergistic effects of rhubarb-gardenia herb pair in cholestatic rats at pharmacodynamic and pharmacokinetic levels.
Dong, LC; Dong, X; Fan, YX; Li, HJ; Li, P; Ma, J; Yu, Q, 2015
)
0.42
" Pathological state is an important factor affecting the efficacy of drugs, the pharmacokinetic behavior of drugs could be significantly changed when people or animal were under different pathological state."( Nine components pharmacokinetic study of rat plasma after oral administration raw and prepared Semen Cassiae in normal and acute liver injury rats.
Cai, B; Jin, J; Peng, S; Qin, K; Sun, K; Xie, L; Yang, B; Zhen, Y, 2019
)
0.51
" Pharmacokinetic studies have demonstrated that aloe-emodin has a poor intestinal absorption, short elimination half-life, and low bioavailability."( Aloe-emodin: A review of its pharmacology, toxicity, and pharmacokinetics.
Dong, X; Fu, J; Liu, Y; Ni, J; Yin, X; You, L; Zeng, Y, 2020
)
0.56
" The method was successfully applied to compare the pharmacokinetic difference between normal and sepsis rats."( Simultaneous Determination of Ten Active Components From Jinhongtang Granule in Rat Plasma by LC-MS/MS and its Application to a Comparative Pharmacokinetic Study in Normal and Sepsis Rats In Vivo and In Vitro.
Fang, B; Huo, X; Ma, X; Sun, C; Tian, X; Wang, Y; Wu, F; Zhang, B; Zhang, Y; Zhao, T, 2023
)
0.91

Compound-Compound Interactions

ExcerptReferenceRelevance
"The aim of the present study was to explore the antileishmanial performance and wound healing effect of exosomes isolated from Wharton Jelly derived mesenchymal stem cells (WJ-MSCs) in combination with aloe-emodin."( Wharton Jelly Derived Mesenchymal Stem Cell's Exosomes Demonstrate Significant Antileishmanial and Wound Healing Effects in Combination with Aloe-Emodin: An in Vitro Study.
Abamor, ES; Allahverdiyev, A; Karaoz, E; Koken, GY, 2022
)
0.72

Bioavailability

Aloe emodin's low bioavailability has been tried to be overcome by structural modifications and nanocarrier systems.

ExcerptReferenceRelevance
" The effective absorption rate constant (Ka) and apparent absorption coefficient (Papp) of aloe-emodin for each segment were determined before and after treated with different concentrations of inhibitors of P-gp and MRP2 respectively."( [Intestinal absorption of aloe-emodin using single-passintestinal perfusion method in rat].
Meng, X; Wang, J; Wang, P; Yang, Y; Zhang, Y, 2011
)
0.37
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" In accordance with the strategy of developing potential drug candidates from natural products, aloe emodin's low bioavailability has been tried to be overcome by structural modifications and nanocarrier systems."( Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer.
Bahadır Acıkara, Ö; Küpeli Akkol, E; Şeker Karatoprak, G; Sobarzo-Sánchez, E; Yücel, Ç, 2022
)
1.21
" In silico ADME studies prediction of AEBH-5a revealed a favorable bioavailability score and prominent drug-likeness profile."( Aloe emodin-conjugated sulfonyl hydrazones as novel type of antibacterial modulators against S. aureus 25923 through multifaceted synergistic effects.
Bheemanaboina, RRY; Deng, Z; Luo, Y; Zhou, CH, 2022
)
2.16

Dosage Studied

ExcerptRelevanceReference
"The TQGART of HPLC fingerprint can be used to determine simultaneously the apparent or single intrinsic solubility parameters for total quantum or intrinsic solubility parameters for single in multiple constitute systems, by which theoretical and technologic platform to study the compatibility rule and dosage form reform of the single CMM will be established."( [Theoretical and experimental studies on apparent solubility parameters of multiple components for Chinese materia medica with HPLC fingerprint].
Dai, R; Deng, K; Fu, J; He, F; Liu, W; Luo, J; Pi, F; Wu, D; Zhou, H, 2010
)
0.36
" The blood samples were collected before dosing and subsequently at 10, 15, 20, 30, 45 min, 1, 2, 4, 8, and 12 h following gavage."( Effect of formula compatibility on the pharmacokinetics of components from Dachengqi Decoction [See Text] in rats.
Chen, GY; Gong, HL; Huang, X; Tang, WF; Wang, J, 2012
)
0.38
"We concluded that acute pancreatitis may significantly affect the pharmacokinetics of Liu-He-Dan while external applied on belly, which indicated the dosage modification in AP."( Effect of acute pancreatitis on the pharmacokinetics of Chinese herbal ointment Liu-He-Dan in anaesthetized rats.
Chen, GY; Chen, WW; Tang, WF; Wan, MH; Xiang, J; Yu, Q; Zhao, XL, 2013
)
0.39
" Slight body-weight loss was randomly observed in all groups treated with the test item and was more evident in the groups dosed at 1000 and 2000 mg/kg bw/day."( Aloe-emodin, a hydroxyanthracene derivative, is not genotoxic in an in vivo comet test.
Ciliutti, P; Cinelli, S; Galli, CL; Marinovich, M; Melzi, G, 2021
)
0.62
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
dihydroxyanthraquinone
aromatic primary alcoholAny primary alcohol in which the alcoholic hydroxy group is attached to a carbon which is itself bonded to an aromatic ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (39)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glp-1 receptor, partialHomo sapiens (human)Potency28.18380.01846.806014.1254AID624417
RAR-related orphan receptor gammaMus musculus (house mouse)Potency21.00420.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency27.30600.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency70.79460.000221.22318,912.5098AID588515
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency11.67100.000657.913322,387.1992AID1259377; AID1259378
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency61.64480.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency39.13000.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency68.58960.001530.607315,848.9004AID1224848; AID1224849; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency8.63490.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency17.90400.000229.305416,493.5996AID1259244; AID588513; AID588514; AID743069; AID743075; AID743078; AID743091
67.9K proteinVaccinia virusPotency11.22020.00018.4406100.0000AID720579
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency0.39810.001024.504861.6448AID588535
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency18.90610.001019.414170.9645AID743094; AID743191
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency7.69590.001723.839378.1014AID743083
importin subunit beta-1 isoform 1Homo sapiens (human)Potency31.62285.804836.130665.1308AID540253
flap endonuclease 1Homo sapiens (human)Potency50.11870.133725.412989.1251AID588795
snurportin-1Homo sapiens (human)Potency31.62285.804836.130665.1308AID540253
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency13.47150.000627.21521,122.0200AID651741; AID720636; AID743202; AID743219
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency17.78280.425612.059128.1838AID504891
GTP-binding nuclear protein Ran isoform 1Homo sapiens (human)Potency31.62285.804816.996225.9290AID540253
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency19.95260.050127.073689.1251AID588590
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency15.35530.001557.789015,848.9004AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency6.85900.002319.595674.0614AID651631
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency15.35530.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
alkaline phosphatase, intestinalHomo sapiens (human)IC50 (µMol)100.00000.565012.905066.3000AID488876
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproproteinHomo sapiens (human)IC50 (µMol)100.00000.125016.260374.8000AID488906
intestinal alkaline phosphatase precursorMus musculus (house mouse)IC50 (µMol)2.88000.259011.870860.3000AID488785
alkaline phosphatase, germ cell type preproproteinHomo sapiens (human)IC50 (µMol)100.00000.110011.386267.2000AID488879
Thioredoxin reductase 1, cytoplasmicRattus norvegicus (Norway rat)IC50 (µMol)180.00000.27201.82606.0000AID551520
TransthyretinHomo sapiens (human)IC50 (µMol)100.00000.16004.292110.0000AID1755162
Replicase polyprotein 1abSevere acute respiratory syndrome-related coronavirusIC50 (µMol)132.00000.00402.92669.9600AID753308
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)1.77000.00002.37899.7700AID1888748
Amine oxidase [flavin-containing] BHomo sapiens (human)IC50 (µMol)21.90000.00001.89149.5700AID1888749
Bifunctional epoxide hydrolase 2Homo sapiens (human)IC50 (µMol)26.80000.00000.54509.1000AID1248116
Bifunctional epoxide hydrolase 2Homo sapiens (human)Ki52.20000.00150.04540.1560AID1248117
Tissue alpha-L-fucosidaseBos taurus (cattle)IC50 (µMol)32.00000.00500.05750.1100AID1688689
P2Y purinoceptor 12Homo sapiens (human)Ki10.00000.00202.82209.8300AID375433
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
interferon gamma precursorHomo sapiens (human)AC5016.62000.128015.173038.6100AID1259418
glycogen synthase kinase-3 alphaHomo sapiens (human)AC50300.00000.013529.7434171.7000AID463203
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (176)

Processvia Protein(s)Taxonomy
signal transductionTransthyretinHomo sapiens (human)
purine nucleobase metabolic processTransthyretinHomo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
symbiont-mediated perturbation of host ubiquitin-like protein modificationReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceBifunctional epoxide hydrolase 2Homo sapiens (human)
positive regulation of gene expressionBifunctional epoxide hydrolase 2Homo sapiens (human)
dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
cholesterol homeostasisBifunctional epoxide hydrolase 2Homo sapiens (human)
stilbene catabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
phospholipid dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
regulation of cholesterol metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
glycolipid catabolic processTissue alpha-L-fucosidaseBos taurus (cattle)
G protein-coupled adenosine receptor signaling pathwayP2Y purinoceptor 12Homo sapiens (human)
monoatomic ion transportP2Y purinoceptor 12Homo sapiens (human)
substrate-dependent cell migration, cell extensionP2Y purinoceptor 12Homo sapiens (human)
G protein-coupled receptor signaling pathwayP2Y purinoceptor 12Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathwayP2Y purinoceptor 12Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayP2Y purinoceptor 12Homo sapiens (human)
hemostasisP2Y purinoceptor 12Homo sapiens (human)
calcium-mediated signalingP2Y purinoceptor 12Homo sapiens (human)
cerebral cortex radial glia-guided migrationP2Y purinoceptor 12Homo sapiens (human)
cell projection organizationP2Y purinoceptor 12Homo sapiens (human)
lamellipodium assemblyP2Y purinoceptor 12Homo sapiens (human)
platelet activationP2Y purinoceptor 12Homo sapiens (human)
positive regulation of integrin activation by cell surface receptor linked signal transductionP2Y purinoceptor 12Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinP2Y purinoceptor 12Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor signaling pathwayP2Y purinoceptor 12Homo sapiens (human)
positive regulation of monoatomic ion transportP2Y purinoceptor 12Homo sapiens (human)
response to axon injuryP2Y purinoceptor 12Homo sapiens (human)
regulation of chemotaxisP2Y purinoceptor 12Homo sapiens (human)
positive regulation of chemotaxisP2Y purinoceptor 12Homo sapiens (human)
establishment of localization in cellP2Y purinoceptor 12Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionP2Y purinoceptor 12Homo sapiens (human)
platelet aggregationP2Y purinoceptor 12Homo sapiens (human)
cellular response to ATPP2Y purinoceptor 12Homo sapiens (human)
visual system developmentP2Y purinoceptor 12Homo sapiens (human)
positive regulation of ruffle assemblyP2Y purinoceptor 12Homo sapiens (human)
regulation of microglial cell migrationP2Y purinoceptor 12Homo sapiens (human)
positive regulation of microglial cell migrationP2Y purinoceptor 12Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (62)

Processvia Protein(s)Taxonomy
hormone activityTransthyretinHomo sapiens (human)
protein bindingTransthyretinHomo sapiens (human)
identical protein bindingTransthyretinHomo sapiens (human)
thyroid hormone bindingTransthyretinHomo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
3'-5'-RNA exonuclease activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
RNA-dependent RNA polymerase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
cysteine-type endopeptidase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA 5'-cap (guanine-N7-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
mRNA (nucleoside-2'-O-)-methyltransferase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
5'-3' RNA helicase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K63-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
K48-linked deubiquitinase activityReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
magnesium ion bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide hydrolase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
toxic substance bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lipid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
protein homodimerization activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lysophosphatidic acid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
alpha-L-fucosidase activityTissue alpha-L-fucosidaseBos taurus (cattle)
G protein-coupled adenosine receptor activityP2Y purinoceptor 12Homo sapiens (human)
G protein-coupled ADP receptor activityP2Y purinoceptor 12Homo sapiens (human)
guanyl-nucleotide exchange factor activityP2Y purinoceptor 12Homo sapiens (human)
G protein-coupled purinergic nucleotide receptor activityP2Y purinoceptor 12Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (35)

Processvia Protein(s)Taxonomy
extracellular regionTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
azurophil granule lumenTransthyretinHomo sapiens (human)
extracellular exosomeTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
double membrane vesicle viral factory outer membraneReplicase polyprotein 1abSevere acute respiratory syndrome-related coronavirus
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomal matrixBifunctional epoxide hydrolase 2Homo sapiens (human)
cytosolBifunctional epoxide hydrolase 2Homo sapiens (human)
extracellular exosomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
plasma membraneP2Y purinoceptor 12Homo sapiens (human)
cell surfaceP2Y purinoceptor 12Homo sapiens (human)
membraneP2Y purinoceptor 12Homo sapiens (human)
cell projection membraneP2Y purinoceptor 12Homo sapiens (human)
cell body membraneP2Y purinoceptor 12Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (145)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1745854NCATS anti-infectives library activity on HEK293 viability as a counter-qHTS vs the C. elegans viability qHTS2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1745855NCATS anti-infectives library activity on the primary C. elegans qHTS viability assay2023Disease models & mechanisms, 03-01, Volume: 16, Issue:3
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
AID1890855Antibacterial activity against Staphylococcus aureus assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis.
AID1172911Neuroprotective effect in Kunming mouse assessed as increase in scopolamine-induced reduction in swim speed at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days measured at day 5 by Morris water maze test r2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1172909Neuroprotective effect in Kunming mouse assessed as increase in scopolamine-induced reduction in time spent in platform crossing at 50 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days measured at day 5 by Mor2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID660321Binding affinity to Escherichia coli pBR322 DNA assessed as DNA migration at 200 uM after 15 mins by agarose gel electrophoresis2011ACS medicinal chemistry letters, Jul-14, Volume: 2, Issue:7
Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.
AID363329Cytotoxicity against MDR1 Pgp overexpressing human HepG2 cells after 24 hrs by MTT assay2008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Comparison of the cytotoxic activities of naturally occurring hydroxyanthraquinones and hydroxynaphthoquinones.
AID1888750Selectivity index, ratio IC50 for recombinant human MAO-B to IC50 for recombinant human MAO-A2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
AID260049Inhibitory activity on PDGF-induced ERK phosphorylation in NIH3T3 cells at 20 uM2006Bioorganic & medicinal chemistry letters, Feb, Volume: 16, Issue:3
Isolation and inhibitory activity against ERK phosphorylation of hydroxyanthraquinones from rhubarb.
AID660313Cytotoxicity against human MCF7 cells after 24 hrs by XTT assay2011ACS medicinal chemistry letters, Jul-14, Volume: 2, Issue:7
Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.
AID1172906Neuroprotective effect in Kunming mouse assessed as reduction in scopolamine-induced impairment in spatial learning and memory at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days measured at day 5 by Morri2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1890852Antibacterial activity against Klebsiella pneumoniae assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis.
AID1890859Antibacterial activity against Pseudomonas aeruginosa assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis.
AID102410Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 10 uM2001Bioorganic & medicinal chemistry letters, Jul-23, Volume: 11, Issue:14
Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity.
AID1172922Neuroprotective effect in Kunming mouse assessed as reversal of scopolamine-induced increase in AChE activity in hippocampus at 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days relative to sham control2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID260052Antiproliferative activity against prostate cancer PC3 cell line at 20 uM by MTT method2006Bioorganic & medicinal chemistry letters, Feb, Volume: 16, Issue:3
Isolation and inhibitory activity against ERK phosphorylation of hydroxyanthraquinones from rhubarb.
AID1172938Inhibition of intracellular ROS generation in rat PC12 cells at 10 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by fluorescence assay relative to control2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID375433Displacement of [3H]PSB0413 from human platelet P2Y12 receptor2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.
AID1890856Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis.
AID1172931Inhibition of H2O2-induced NO production in rat PC12 cells at 5 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs relative to control2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID260054Antifungal activity against Gibberella zeae at 0.5 mg/ml2006Bioorganic & medicinal chemistry letters, Feb, Volume: 16, Issue:3
Isolation and inhibitory activity against ERK phosphorylation of hydroxyanthraquinones from rhubarb.
AID67653Inhibitory activity against Porcine Pancreatic Elastase (PPE) at 63 uM concentration1992Journal of medicinal chemistry, May-01, Volume: 35, Issue:9
Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G.
AID1172939Inhibition of intracellular ROS generation in rat PC12 cells at 20 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by fluorescence assay relative to control2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID343962Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Correlation between reduction potentials and inhibitions of Epstein-Barr virus activation by anthraquinone derivatives.
AID1248119Non-competitive inhibition of sEH (unknown origin) using PHOME as substrate assessed as formation of 6-methoxy-2-naphthaldehyde measured during 30 mins by Lineweaver-Burk plot analysis2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe.
AID1172943Neuroprotective effect in po dosed Kunming mouse assessed as increase in scopolamine-induced reduction in time spent in platform crossing administered qd for 15 days followed by 1 hr prior to trial session for 6 days by Morris water maze test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1172905Neuroprotective effect in Kunming mouse assessed as reversal of scopolamine-induced effect on spatial memory performance at 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days by Morris water maze test relative to 2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1172923Inhibition of AChE (unknown origin) at 40 ug/ml by Ellman's method2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1172924Inhibition of AChE (unknown origin) by Ellman's method2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1172928Cytoprotective effect against H2O2-induced cell death in rat PC12 cells at 20 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID260051Antiproliferative activity against human epidermal carcinoma A431 cell line at 20 uM by MTT method2006Bioorganic & medicinal chemistry letters, Feb, Volume: 16, Issue:3
Isolation and inhibitory activity against ERK phosphorylation of hydroxyanthraquinones from rhubarb.
AID753308Inhibition of recombinant SARS coronavirus 3C-like protease trans-cleavage activity by ELISA2013Bioorganic & medicinal chemistry, Jul-01, Volume: 21, Issue:13
Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava.
AID1172937Inhibition of intracellular ROS generation in rat PC12 cells at 5 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by fluorescence assay relative to control2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID335924Antiplatelet activity in rat platelet rich plasma assessed as drug level causing inhibition of collagen-stimulated platelet aggregation pretreated 2 mins before collagen challenge
AID1172933Inhibition of H2O2-induced NO production in rat PC12 cells at 20 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs relative to control2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1072529Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV surface antigen secretion2014European journal of medicinal chemistry, Mar-21, Volume: 75A review of non-nucleoside anti-hepatitis B virus agents.
AID1172941Neuroprotective effect in po dosed Kunming mouse assessed as reduction in scopolamine-induced escape latency administered qd for 15 days followed by 1 hr prior to trial session for 6 days by Morris water maze test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID132503Compound was tested for inhibitory activity against nitric oxide production in LPS-activated mouse peritoneal macrophages (*,showed cytotoxicity at 30 uM)2000Bioorganic & medicinal chemistry letters, Feb-21, Volume: 10, Issue:4
Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages.
AID1062996Cytotoxicity against human A2780 cells2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Isolation of antiplasmodial anthraquinones from Kniphofia ensifolia, and synthesis and structure-activity relationships of related compounds.
AID335923Antiplatelet activity in rat platelet rich plasma assessed as drug level causing inhibition of ADP-stimulated platelet aggregation pretreated 2 mins before ADP challenge
AID19840Partition coefficient of compound in octanol and water by Fragmental method of Leo/Hansch2003Bioorganic & medicinal chemistry letters, Feb-24, Volume: 13, Issue:4
Determination of active components in rhubarb and study of their hydrophobicity by micellar electrokinetic chromatography.
AID1726357Cytotoxicity against human HEK293 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2021RSC medicinal chemistry, May-26, Volume: 12, Issue:5
Design, synthesis, and biological evaluation of pyrazole-linked aloe emodin derivatives as potential anticancer agents.
AID1172914Neuroprotective effect in Kunming mouse assessed as reduction in scopolamine-induced increase in MDA level in hippocampus at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days relative to control2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID285177Effect on Streptococcus mutans LMG 14558 assessed as inhibition of biofilm formation in modified Robbin's device at 50 ug/ml relative to BHIS control2007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
In vitro inhibition of Streptococcus mutans biofilm formation on hydroxyapatite by subinhibitory concentrations of anthraquinones.
AID102409Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 1 uM2001Bioorganic & medicinal chemistry letters, Jul-23, Volume: 11, Issue:14
Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity.
AID335922Antiplatelet activity in rat platelet rich plasma assessed as drug level causing inhibition of arachidonic acid-stimulated platelet aggregation pretreated 2 mins before arachidonic acid challenge
AID67321Inhibitory activity against Human Leukocyte Elastase (HLE) at 63 uM concentration1992Journal of medicinal chemistry, May-01, Volume: 35, Issue:9
Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G.
AID1072528Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV e antigen secretion2014European journal of medicinal chemistry, Mar-21, Volume: 75A review of non-nucleoside anti-hepatitis B virus agents.
AID1172919Neuroprotective effect in Kunming mouse assessed as reversal of scopolamine-induced reduction in ACh level in hippocampus at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID660315Cytotoxicity against human NAR cells after 24 hrs by XTT assay2011ACS medicinal chemistry letters, Jul-14, Volume: 2, Issue:7
Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.
AID1172903Neuroprotective effect in Kunming mouse assessed as reduction in scopolamine-induced escape latency at 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days by Morris water maze test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1666597Induction of DNA damage in human SU8686 cells assessed as increase in gammaH2AX phosphorylation at ser193 at cytotoxic IC50 in presence of 0.3 uM doxorubicin by fluorometry method2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
Targeting the DNA damage response (DDR) by natural compounds.
AID660317Cytotoxicity against doxorubicin-resistant human MCF7 cells assessed as cell viability at 20 uM after 24 hrs by XTT assay2011ACS medicinal chemistry letters, Jul-14, Volume: 2, Issue:7
Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.
AID551520Inhibition of rat liver cytosolic TrxR1 by spectrophotometry2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthrones.
AID1072523Antiviral activity against Hepatitis B virus infected in human HepG2.2.15 cells assessed as decrease in HBV DNA production2014European journal of medicinal chemistry, Mar-21, Volume: 75A review of non-nucleoside anti-hepatitis B virus agents.
AID1072538Inhibition of bovine xanthine oxidase using xanthine as substrate at 50 ug/ml2014European journal of medicinal chemistry, Mar-21, Volume: 75Design, synthesis and molecular modeling of aloe-emodin derivatives as potent xanthine oxidase inhibitors.
AID1688689Inhibition of bovine kidney alpha-fucosidase using PNPG as substrate incubated for 10 mins by spectrophotometric method2020European journal of medicinal chemistry, Feb-15, Volume: 188Discovery of novel pyrido-pyrrolidine hybrid compounds as alpha-glucosidase inhibitors and alternative agent for control of type 1 diabetes.
AID660318Cytotoxicity against human SKOV3 cells assessed as cell viability at 20 uM after 24 hrs by XTT assay2011ACS medicinal chemistry letters, Jul-14, Volume: 2, Issue:7
Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.
AID1172942Neuroprotective effect in po dosed Kunming mouse assessed as increase in scopolamine-induced reduction in time spent in target quadrant administered qd for 15 days followed by 1 hr prior to trial session for 6 days by Morris water maze test2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1688684Inhibition of Saccharomyces cerevisiae alpha-glucosidase using maltose as substrate preincubated for 5 mins followed by substrate addition and measured after 15 mins by LC-TQ-MS/MS analysis2020European journal of medicinal chemistry, Feb-15, Volume: 188Discovery of novel pyrido-pyrrolidine hybrid compounds as alpha-glucosidase inhibitors and alternative agent for control of type 1 diabetes.
AID736936Inhibition of AChE in rat cortex using acetylthiocholine iodide as substrate at 100 ug/ml preincubated with enzyme for 10 mins prior to substrate addition by Ellman's colorimetric method2013Bioorganic & medicinal chemistry, Mar-01, Volume: 21, Issue:5
Synthesis, biological evaluation and molecular modeling of aloe-emodin derivatives as new acetylcholinesterase inhibitors.
AID363328Cytotoxicity against MDR1 Pgp under-expressing human HCT116 cells after 24 hrs by MTT assay2008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Comparison of the cytotoxic activities of naturally occurring hydroxyanthraquinones and hydroxynaphthoquinones.
AID1172926Cytoprotective effect against H2O2-induced cell death in rat PC12 cells at 5 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1172935Inhibition of H2O2-induced LDH release in rat PC12 cells at 5 to 20 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs relative to control2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1890860Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis.
AID1688692Inhibition of jack bean alpha-mannosidase at 1 mM using PNPG as substrate incubated for 10 mins by spectrophotometric method2020European journal of medicinal chemistry, Feb-15, Volume: 188Discovery of novel pyrido-pyrrolidine hybrid compounds as alpha-glucosidase inhibitors and alternative agent for control of type 1 diabetes.
AID1755162Inhibition of acid-mediated aggregation of TTR V30M mutant (unknown origin) expressed in Escherichia coli pretreated for 30 mins at pH 7 followed by protein dilution in acetate buffer and further incubated for 96 hrs at pH 4.6 by thioflavin-T fluorescence2021Bioorganic & medicinal chemistry, 08-15, Volume: 44Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.
AID1890853Antibacterial activity against Enterococcus faecalis assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis.
AID660319Cytotoxicity against doxorubicin-resistant human NAR cells assessed as cell viability at 100 uM after 24 hrs by XTT assay2011ACS medicinal chemistry letters, Jul-14, Volume: 2, Issue:7
Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.
AID660314Cytotoxicity against human SKOV3 cells after 24 hrs by XTT assay2011ACS medicinal chemistry letters, Jul-14, Volume: 2, Issue:7
Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.
AID375434Displacement of [3H]PSB0413 from human platelet P2Y12 receptor at 10 uM2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors.
AID102411Compound was tested for enhancement of proliferation of MCF-7 cell line at a concentration 3 uM2001Bioorganic & medicinal chemistry letters, Jul-23, Volume: 11, Issue:14
Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structure-requirement of hydroxyanthraquinones for estrogenic activity.
AID1172927Cytoprotective effect against H2O2-induced cell death in rat PC12 cells at 10 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1248115Inhibition of sEH (unknown origin) using PHOME as substrate assessed as formation of 6-methoxy-2-naphthaldehyde at 100 uM measured during 1 hr by fluorescence photometric analysis relative to control2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID260053Antifungal activity against Fusarium oxysporum at 0.5 mg/ml2006Bioorganic & medicinal chemistry letters, Feb, Volume: 16, Issue:3
Isolation and inhibitory activity against ERK phosphorylation of hydroxyanthraquinones from rhubarb.
AID1248116Inhibition of sEH (unknown origin) using PHOME as substrate assessed as formation of 6-methoxy-2-naphthaldehyde measured during 1 hr by fluorescence photometric analysis2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe.
AID1172930Inhibition of H2O2-induced NO production in rat PC12 cells incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs relative to control2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID285171Activity against planktonic Streptococcus mutans LMG 145582007Antimicrobial agents and chemotherapy, Apr, Volume: 51, Issue:4
In vitro inhibition of Streptococcus mutans biofilm formation on hydroxyapatite by subinhibitory concentrations of anthraquinones.
AID1890858Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis.
AID1172912Neuroprotective effect in Kunming mouse assessed as increase in scopolamine-induced reduction in SOD level in hippocampus at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days relative to control2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1726356Anticancer activity against mouse B16-F10 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2021RSC medicinal chemistry, May-26, Volume: 12, Issue:5
Design, synthesis, and biological evaluation of pyrazole-linked aloe emodin derivatives as potential anticancer agents.
AID660311Cytotoxicity against human MOLT4 cells after 24 hrs by XTT assay2011ACS medicinal chemistry letters, Jul-14, Volume: 2, Issue:7
Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.
AID1726355Anticancer activity against human HepG2 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2021RSC medicinal chemistry, May-26, Volume: 12, Issue:5
Design, synthesis, and biological evaluation of pyrazole-linked aloe emodin derivatives as potential anticancer agents.
AID1890854Antibacterial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis.
AID1890861Antibacterial activity against Acinetobacter baumannii assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis.
AID1083211Bactericidal activity against Erwinia amylovora 295/93 assessed as growth inhibition in King's B full medium measured at pH 7.2 after overnight incubation by suspension culture assay2012Journal of agricultural and food chemistry, Dec-12, Volume: 60, Issue:49
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
AID660312Cytotoxicity against human OVCAR3 cells after 24 hrs by XTT assay2011ACS medicinal chemistry letters, Jul-14, Volume: 2, Issue:7
Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.
AID52627Inhibitory activity against Chymotrypsinogen at 63 uM concentration1992Journal of medicinal chemistry, May-01, Volume: 35, Issue:9
Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G.
AID260055Antifungal activity against Phytopthora infestans at 0.5 mg/ml2006Bioorganic & medicinal chemistry letters, Feb, Volume: 16, Issue:3
Isolation and inhibitory activity against ERK phosphorylation of hydroxyanthraquinones from rhubarb.
AID1890857Antibacterial activity against Escherichia coli assessed as inhibition of bacterial growth measured after 24 hrs by CLSI based broth microdilution method2022Bioorganic & medicinal chemistry letters, 05-15, Volume: 64Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis.
AID1248117Non-competitive inhibition of sEH (unknown origin) using PHOME as substrate assessed as formation of 6-methoxy-2-naphthaldehyde measured during 30 mins by Dixon plot analysis2015Bioorganic & medicinal chemistry, Oct-15, Volume: 23, Issue:20
Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe.
AID1172925Cytotoxicity against rat PC12 cells at 1 to 20 ug/ml by MTT assay2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID1062995Antiplasmodial activity against chloroquine-resistant ring stage Plasmodium falciparum Dd2 after 72 hrs by SYBR Green 1-based fluorescence assay2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Isolation of antiplasmodial anthraquinones from Kniphofia ensifolia, and synthesis and structure-activity relationships of related compounds.
AID260050Inhibitory activity on EGF-induced ERK phosphorylation in prostate cancer PC3 cell line at 20 uM2006Bioorganic & medicinal chemistry letters, Feb, Volume: 16, Issue:3
Isolation and inhibitory activity against ERK phosphorylation of hydroxyanthraquinones from rhubarb.
AID1172907Neuroprotective effect in Kunming mouse assessed as increase in scopolamine-induced reduction in time spent in target quadrant at 50 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days measured at day 5 by Morri2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID658253Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication after 72 hrs by EGFP assay2012European journal of medicinal chemistry, Jun, Volume: 52Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1888748Inhibition of recombinant human MAO-A expressed in baculovirus infected BTI insect cells using kynuramine as substrate after 20 mins by fluorescence spectrophotometric assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
AID1172918Neuroprotective effect in Kunming mouse assessed as reversal of scopolamine-induced increase in AChE activity in hippocampus at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID134176Compound (at 10 uM) was tested for inhibition against nitric oxide production in LPS-activated mouse peritoneal macrophages2000Bioorganic & medicinal chemistry letters, Feb-21, Volume: 10, Issue:4
Effects of stilbene constituents from rhubarb on nitric oxide production in lipopolysaccharide-activated macrophages.
AID1688687Inhibition of Saccharomyces cerevisiae alpha-glucosidase using PNPG as substrate incubated for 10 mins by spectrophotometric method2020European journal of medicinal chemistry, Feb-15, Volume: 188Discovery of novel pyrido-pyrrolidine hybrid compounds as alpha-glucosidase inhibitors and alternative agent for control of type 1 diabetes.
AID1726354Anticancer activity against human MCF-7 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2021RSC medicinal chemistry, May-26, Volume: 12, Issue:5
Design, synthesis, and biological evaluation of pyrazole-linked aloe emodin derivatives as potential anticancer agents.
AID660324Cytotoxicity against human lymphocytes assessed as cell viability at 20 uM after 24 hrs by XTT assay relative to untreated control2011ACS medicinal chemistry letters, Jul-14, Volume: 2, Issue:7
Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.
AID1072539Inhibition of bovine xanthine oxidase using xanthine as substrate measured for 6 mins at 50 uM at 25 degC by spectrophotometry2014European journal of medicinal chemistry, Mar-21, Volume: 75Design, synthesis and molecular modeling of aloe-emodin derivatives as potent xanthine oxidase inhibitors.
AID48375Inhibitory activity against Cathepsin G (CatG) at 63 uM concentration1992Journal of medicinal chemistry, May-01, Volume: 35, Issue:9
Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G.
AID1172913Neuroprotective effect in Kunming mouse assessed as increase in scopolamine-induced reduction in GPx level in hippocampus at 25 to 100 mg/kg, po qd administered for 15 days followed by 1 hr prior to trial session for 6 days relative to control2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID658255Cytotoxicity against human Huh7.5.1 cells by MTT assay2012European journal of medicinal chemistry, Jun, Volume: 52Discovery of flavonoid derivatives as anti-HCV agents via pharmacophore search combining molecular docking strategy.
AID660326Toxicity in Wistar rat erythrocytes assessed as hemolysis at 50 uM after 1 hr2011ACS medicinal chemistry letters, Jul-14, Volume: 2, Issue:7
Targeting anthracycline-resistant tumor cells with synthetic aloe-emodin glycosides.
AID1726353Anticancer activity against human MDA-MB-231 cells assessed as cell growth inhibition measured after 48 hrs by MTT assay2021RSC medicinal chemistry, May-26, Volume: 12, Issue:5
Design, synthesis, and biological evaluation of pyrazole-linked aloe emodin derivatives as potential anticancer agents.
AID1172932Inhibition of H2O2-induced NO production in rat PC12 cells at 10 ug/ml incubated for 24 hrs prior to H2O2 challenge measured after 2 hrs relative to control2014Bioorganic & medicinal chemistry letters, Dec-01, Volume: 24, Issue:23
Protective effects of aloe-emodin on scopolamine-induced memory impairment in mice and H₂O₂-induced cytotoxicity in PC12 cells.
AID551521Inhibition of rat liver mitochondrial TrxR2 by spectrophotometry2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthrones.
AID755276Antidiabetic nephropathic activity in rat HBZY-1 cells assessed as inhibition of high concentration glucose-induced IL-6 production at 10 uM treated 1 hr before glucose challenge measured after 24 hrs by ELISA2013Bioorganic & medicinal chemistry letters, Jul-01, Volume: 23, Issue:13
Anthraquinone derivatives from Rumex plants and endophytic Aspergillus fumigatus and their effects on diabetic nephropathy.
AID1888749Inhibition of recombinant human MAO-B expressed in baculovirus infected BTI insect cells using kynuramine as substrate after 20 mins by fluorescence spectrophotometric assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (283)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (1.41)18.7374
1990's17 (6.01)18.2507
2000's84 (29.68)29.6817
2010's116 (40.99)24.3611
2020's62 (21.91)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.51 (24.57)
Research Supply Index5.69 (2.92)
Research Growth Index5.42 (4.65)
Search Engine Demand Index120.43 (26.88)
Search Engine Supply Index2.98 (0.95)

This Compound (51.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews8 (2.72%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other286 (97.28%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]